Schrodinger
SDGR Small CapHealthcare · Health Information Services
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Schrodinger en bref
Schrodinger (SDGR) is currently trading at 13,75 € with a market capitalization of 1,0 Md €. The 52-week range spans from 9,56 € to 20,73 €; the current price is 33.6% below the yearly high. Year-over-year revenue growth stands at -1.6%.
💰 Dividende
Schrodinger currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
8 analystes évaluent Schrodinger (SDGR) au consensus : None. L'objectif de cours moyen est de 18,22 €, soit un potentiel de +32.46% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 11,34 € à 26,18 €.
Schrodinger : la thèse d'investissement en détail
Schrodinger (SDGR) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Revenue is contracting at -1.6% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 24.89% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.
À surveiller
- The analyst consensus price target implies 32.46% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 55.33% — signe d'un pouvoir de fixation des prix
- Bilan solide avec faible endettement (D/E 34.13)
- –CA en contraction (-1.6% sur un an)
- –Actuellement non rentable
- –Positions vendeuses élevées (24.89%)
- –Free cash flow négatif
Aperçu technique
The price is in a transition zone relative to the moving averages — no clear signal.
Profil de risque
The data points to above-average price swings, elevated short interest (24.89%).
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Schrodinger?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news